Mach1
Payments companies reported to CMS as associated with Mach1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mach1, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mach1
These are the largest totals companies reported as associated with Mach1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bhavanadhar Penta | New York, NY | Interventional Cardiology | $80.02 |
| Rakhee Makhija | Mckinney, TX | Interventional Cardiology | $80.02 |
| Pier Pasquale Leone | New York, NY | Interventional Cardiology | $80.02 |
| Frank Kalaba | New York, NY | $80.02 | |
| Chandrashekar Bohra | Ocala, FL | Cardiovascular Disease | $80.01 |
| Yash Jobanputra | Worcester, MA | Cardiovascular Disease | $80.01 |
| Tawseef Dar | Norfolk, VA | Internal Medicine | $80.01 |
| Vishal Dhulipala | Sumter, SC | Interventional Cardiology | $80.01 |
| Anton Camaj | New York, NY | Interventional Cardiology | $80.01 |
| David Power | Rego Park, NY | Cardiovascular Disease | $40.02 |
Prescribed Mach1?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.